Research Nester’s recent market research analysis on “Blood Culture Tests Market: Global Demand Analysis & Opportunity Outlook 2035” delivers a detailed competitors analysis and a detailed overview of the global blood culture tests market in terms of market segmentation by application, end-user, and by region.
Growing Demand for Blood Tests with Increasing Bloodstream Infections to Promote Global Market Share of Blood Culture Tests
The global blood culture tests market is estimated to grow majorly on account of the increased transmission of blood infections among people. Growing awareness of people regarding blood-borne diseases across the world and the need for accurate diagnostic tests is estimated to drive market growth. The increasing health expenditure owing to the rising concern of the government on healthcare needs is propelling the market growth. Further, the rising advancements in the technology of blood culture testing to improve the results and speed of testing are expected to promote market growth. Escalating treatment options for blood disorders is likely to propel the market growth. Every year more than 30 million people are affected by sepsis and kill over a million people as per the World Health Organization.
For instance, as per the Centers for Disease Control and Prevention, sepsis led to 1.7 million cases per annum in the United States and was reported as one of the major causes of hospitalization. Also, it caused the death of over 270,000 people with the highest number of deaths in the hospital in the U.S. every year. The increasing incidence of sepsis across the world with the growing number of geriatric populations is anticipated to propel the market growth. Moreover, the occurrence of a pandemic is also estimated to promote the cause of spread thereby fueling the growth of the market during the forecast period.
Some of the major growth factors and challenges that are associated with the growth of the global blood culture tests market are:
Growth Drivers:
· Rising demand for accurate blood diagnostic tests
· Increasing spending on research and development of new solutions
Challenges:
The sensitivity issue of blood testing and the risk of contamination in the blood culture samples are some of the major factors anticipated to hamper the global market size of blood culture tests. Moreover, the high cost of blood culture testing is estimated to hinder market growth owing to the less availability of resources in low and middle-income countries. The less availability and lack of import and export facilities owing to low government funds in these regions are estimated to delay the diagnosis and treatment of many blood disorders.
Access our detailed report at:
https://www.researchnester.com/reports/blood-culture-tests-market/4851
The global blood culture testing market is divided into two end-user segments: hospitals and academic research. The hospital segment is expected to generate the most revenue by the end of 2035, with a strong CAGR over the projection period. The rise in the number of people living with chronic diseases and the rising number of patients with proper treatment needs is driving the market segment growth. Other growth opportunities in the market segment are attributed to the growing number of hospitals across the world. The availability of specialized physicians and doctors in hospitals to provide a wide range of treatment options is propelling the market segment growth in the coming years. Additionally, the presence of all resources required to provide knowledge associated with the rare issues is estimated to drive the market segment growth. As of 2022, there are more than 6100 hospitals in use in the United States.
By region, the Asia Pacific blood culture tests market is to generate the highest revenue by the end of 2035. This growth is anticipated by increasing the incidence of infectious diseases across the region. The rising bacterial infections leading to sepsis and bacteremia are also propelling the market growth. The growing laboratory facilities in the region and developmental activities conducted to improve the infrastructure of the healthcare sector to improve the health needs of the people are estimated to hike the market growth. The rising awareness of people about sepsis and other bloodstream infections is likely to promote market growth in the region. The increasing need for point-of-care testing for the fast diagnosis of infections in the Asia Pacific region is estimated to drive the market growth.
This report also provides the existing competitive scenario of some of the key players of the global blood culture tests market which includes company profiling of BioMeurieux SA, Becton, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Bruker Corporation, Luminex Corporation, Danaher Corporation, Abbott Laboratories, Roche Diagnostics International Ltd., Cepheid Inc., T2 Biosystems, Inc., and others.
Request Report Sample@
https://www.researchnester.com/sample-request-4851 +
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: [email protected]
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919